Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 887
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +12.2%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 1,351–1,400 of 1,505 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00003551	Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer	completed	Phase 2	—	Emory UniversityOTHER	1	Jun 21, 2013	clinicaltrials
NCT00005045	Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer	completed	Phase 2	—	Eastern Cooperative Oncology GroupNETWORK	3	Jun 21, 2013	clinicaltrials